Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (ATYR)
NASDAQ:ATYR
Holding ATYR?
Track your performance easily
ATYR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.14 - $3.80
Previous Close$2.98
Volume1.27M
Average Volume (3M)836.92K
Market Cap
$250.15M
Enterprise Value$197.55M
Total Cash (Recent Filing)$65.99M
Total Debt (Recent Filing)$13.57M
Price to Earnings (P/E)―
Beta1.22
Next Earnings
Mar 26, 2025EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.94
Shares Outstanding83,942,407
10 Day Avg. Volume819,876
30 Day Avg. Volume836,918
Standard Deviation0.20
R-Squared0.08
Alpha0.00205
Financial Highlights & Ratios
Price to Book (P/B)3.83
Price to Sales (P/S)1085.89
Price to Cash Flow (P/CF)-4.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue840.62
Enterprise Value/Gross Profit559.62
Enterprise Value/Ebitda-3.18
Forecast
1Y Price Target
$19.80Price Target Upside553.47% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
aTyr Pharma News
PremiumCompany Announcements
aTyr Pharma Reports Q3 2024 Financial Results
Ownership Overview
2.65% Insiders
29.94% Mutual Funds
14.79% Other Institutional Investors
48.93% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ATYR FAQ
What was aTyr Pharma’s price range in the past 12 months?
aTyr Pharma lowest stock price was $1.14 and its highest was $3.80 in the past 12 months.
What is aTyr Pharma’s market cap?
Currently, no data Available
When is aTyr Pharma’s upcoming earnings report date?
aTyr Pharma’s upcoming earnings report date is Mar 26, 2025 which is in 123 days.
How were aTyr Pharma’s earnings last quarter?
aTyr Pharma released its earnings results on Nov 07, 2024. The company reported -$0.23 earnings per share for the quarter, missing the consensus estimate of -$0.22 by -$0.01.
Is aTyr Pharma overvalued?
According to Wall Street analysts aTyr Pharma’s price is currently Undervalued.
Does aTyr Pharma pay dividends?
aTyr Pharma does not currently pay dividends.
What is aTyr Pharma’s EPS estimate?
aTyr Pharma’s EPS estimate is -$0.23.
How many shares outstanding does aTyr Pharma have?
aTyr Pharma has 83,942,406 shares outstanding.
What happened to aTyr Pharma’s price movement after its last earnings report?
aTyr Pharma reported an EPS of -$0.23 in its last earnings report, missing expectations of -$0.22. Following the earnings report the stock price went up 0.645%.
Which hedge fund is a major shareholder of aTyr Pharma?
Among the largest hedge funds holding aTyr Pharma’s share is Woodline Partners LP. It holds aTyr Pharma’s shares valued at 3M.
---
aTyr Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.80 (553.47% Upside)
$19.80 (553.47% Upside)
Blogger Sentiment
Bullish
ATYR Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 387.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 8.8%
Last 30 Days ▲ 8.8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
161.40%
12-Months-Change
Fundamentals
Return on Equity
-77.96%
Trailing 12-Months
Asset Growth
-26.75%
Trailing 12-Months
Company Description
aTyr Pharma
aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
---
ATYR Earnings Call
Q4 2024
0:00 / 0:00
---
ATYR Stock 12 Month Forecast
Average Price Target
$19.80
▲(553.47% Upside)
Technical Analysis
Best Analysts Covering ATYR
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+55.58%
reiterated a buy rating 7 months ago
Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +55.58% per trade.
---